abagovomab 0
abciximab 9
abituzumab 3
abrilumab 0
actoxumab 3
adalimumab 7
aducanumab 0
afasevikumab 0
alacizumab_pegol 0
alemtuzumab 8
alirocumab 0
amatuximab 7
andecaliximab 0
anifrolumab 3
anrukinzumab 5
aprutumab 3
aprutumab_ixadotin 3
arcitumomab 4
ascrinvacumab 0
atezolizumab 4
atinumab 9
avelumab 0
basiliximab 0
bavituximab 5
begelomab 0
benralizumab 0
bevacizumab_beta 0
bezlotoxumab 3
bimagrumab 3
bleselumab 0
blinatumomab 6
blosozumab 7
bococizumab 6
brazikumab 0
brentuximab_vedotin 0
briakinumab 4
brodalumab 0
brolucizumab 10
brontictuzumab 3
burosumab 4
cabiralizumab 3
camrelizumab 0
canakinumab 3
cantuzumab_ravtansin 7
carlumab 3
carotuximab 0
cergutuzumab_amunaleukin2 8
cergutuzumab_amunaleukin 8
certolizumab_pegol 0
cetiximab 10
citatuzumab_bogatox 6
cixutumumab 8
clivatuzumab_tetraxetan 0
codrituzumab 9
conatumumab 3
concizumab 3
crenezumab 0
crizanlizumab 3
crotedumab 5
dacetuzumab 7
daclizumab 5
dalotuzumab 3
dapirolizumab_pegol 3
daratumumab 7
dectrekumab 3
demcizumab 7
denosumab 3
depatuxizumab 0
depatuxizumab_mafodotin 0
dezamizumab 0
dinutuximab 7
diridavumab 0
domagrozumab 0
drozitumab 0
duligotuzumab 6
durvalumab 0
dusigitumab 0
efalizumab 10
efungumab 0
eldelumab 3
elezanumab 0
elgemtumab 0
elotuzumab 0
emactuzumab 4
emapalumab 3
emibetuzumab 0
enavatuzumab 6
enfortumab_vedotin 0
enoblituzumab 0
enokizumab 0
enoticumab 3
ensituximab 6
eptinezumab 0
erenumab 0
etaracizumab 7
etrolizumab 7
evinacumab 4
evolocumab 3
farletuzumab 0
fasinumab 3
fezakinumab 0
fibatuzumab 0
ficlatuzumab 0
firivumab 8
flanvotumab 0
fletikumab 3
foralumab 0
foravirumab 0
fremanezumab 9
fresolimumab 9
fulranumab 3
futuximab 3
galcanezumab 0
ganitumab 7
gantenerumab 0
gemetuzumab 6
gemtuzumab2 7
gemtuzumab 5
gevokizumab 10
girentuximab 5
glembatumumab 4
glembatumumab_vedotin 4
guselkumab 11
ibalizumab 6
ibritumomab 0
icrucumab 0
idarucizumab 3
ifabotuzumab 0
imalumab 7
imgatuzumab 0
inclacumab 3
indatuximab_ravtansin 9
indusatumab 3
inebilizumab 5
intetumumab 3
iodine_girentuximab 3
ipilimumab 0
iratumumab 0
isatuximab 0
itolizumab 0
ixekizumab 6
labetuzumab_govitecan 8
lambrolizumab 6
lampalizumab 4
lanadelumab 8
landogrozumab 0
laprituximab 3
lebrikizumab 7
lendalizumab 5
lenzilumab 0
lifastuzumab_vedotin 0
ligelizumab 5
lilotomab 4
lirilumab 0
lodelcizumab 6
lokivetmab 3
lorvotuzumab_mertansin 0
lucatumumab 3
lumretuzumab 0
lupartumab 0
lutikizumab 6
margetuximab 8
milatuzumab 3
mirvetuximab 5
mirvetuximab_soravtansin 5
modotuximab 6
mogamulizumab 3
monalizumab 10
motavizumab 7
moxetumomab_pasudotox 6
namilumab 0
naratuximab 4
naratuximab_emtansin 4
narnatumab 6
navicixizumab2 7
navicixizumab 7
navivumab 3
necitumumab 0
nemolizumab 7
nesvacumab 0
nivolumab 3
obiltoxaximab 0
obinutuzumab 0
ocaratuzumab 6
ofatumumab 0
olaratumab 0
olokizumab 8
omalizumab 7
onartuzumab 0
ontuxizumab 0
opicinumab 9
orticumab 0
otelixizumab 6
oxelumab 0
ozanezumab 3
pamrevlumab 0
panobacumab 3
parsatuzumab 3
pasotuxizumab 7
pateclizumab 5
patritumab 4
pembrolizumab 6
perakizumab 0
pidilizumab 3
pinatuzumab_vedotin 0
plozalizumab 4
pogalizumab 0
polatuzumab_vedotin 6
ponezumab 6
prezalumab 7
pritoxaximab 7
quilizumab 4
racotumomab 6
radretumab 0
ralpancizumab 8
ramucirumab 3
ranevetmab 9
ranibizumab 0
refanezumab 3
remtolumab 5
rilotumumab 3
rinucumab 0
risankizumab 0
rituximab 0
rivabazumab 3
robatumumab 9
roledumab 5
romosozumab 3
rontalizumab 4
rosmantuzumab 3
rozanolixizumab 4
sacituzumab 6
sacituzumab_govitecan 6
samalizumab 6
sapelizumab 5
sarilumab 0
secukinumab 0
seribantumab 0
setoxaximab 9
sifalimumab 0
siltuximab 6
simtuzumab 7
sirukumab 3
solanezumab 10
solitomab 3
stamulumab 0
suptavumab 3
suvizumab 0
tabalumab 0
tadocizumab 0
tamtuvetmab 4
tanezumab 12
tarextumab 3
tavolixizumab 0
telisotuzumab 9
teplizumab 3
tesidolumab 0
tezepelumab 4
tigatuzumab 8
tildrakizumab 6
timolumab 0
tisotumab 0
tosatoxumab 11
tositumomab 0
tralokinumab 7
trastuzumab 7
tregalizumab 7
trevogrumab 5
ublituximab 3
urelumab 0
ustekinumab 6
utomilumab 3
vadastuximab 0
vadastuximab_talirin 0
vandortuzumab_vedotin 0
vantictumab 3
vanucizumab2 0
vanucizumab 3
varlilumab 0
vatelizumab 7
vedolizumab 0
veltuzumab 0
vesencumab 0
vorsetuzumab 0
vorsetuzumab_mafodotin 0
vunakizumab 3
xentuzumab 0
zatuximab 6
